A controlled trial of acyclovir in stable chronic HBsAg, HBeAg-positive carriers
- 1 January 1986
- journal article
- clinical trial
- Published by Elsevier in Journal of Hepatology
- Vol. 3, S123-S127
- https://doi.org/10.1016/s0168-8278(86)80110-6
Abstract
No abstract availableKeywords
This publication has 13 references indexed in Scilit:
- Thrice weekly lymphoblastoid interferon is effective in inhibiting hepatitis B virus replicationLiver International, 1984
- Detection of Hepatitis B Virus DNA in Serum by a Simple Spot Hybridization Technique: Comparison with Results for Other Viral MarkersHepatology, 1983
- Acyclovir in hepatitis B antigen—positive chronic liver disease: inhibition of viral replication and transient renal impairment with iv bolus administrationJournal of Antimicrobial Chemotherapy, 1983
- Spontaneous Disappearance of Viral Replication and Liver Cell Inflammation in Hbsag–Positive Chronic Active Hepatitis: Results of A Placebo Vs. Interferon TrialHepatology, 1982
- Successful treatment of HBs and HBeAg positive chronic liver disease: prolonged inhibition of viral replication by highly soluble adenine arabinoside 5'-monophosphate (ARA-AMP).Gut, 1982
- Antiviral treatment of chronic hepatitis B virus infection: pharmacokinetics and side effects of interferon and adenine arabinoside alone and in combinationAntimicrobial Agents and Chemotherapy, 1982
- ACYCLOVIR INHIBITS HEPATITIS B VIRUS REPLICATION IN MANThe Lancet, 1982
- Effect of Liver Disease on Pharmacokinetics and Toxicity of 9- -D-Arabinofuranosyladenine-5'-PhosphateThe Journal of Infectious Diseases, 1981
- Seroconversion from Hepatitis B e Antigen to Antibody in Chronic Type B HepatitisAnnals of Internal Medicine, 1981
- Antiviral Treatment of Chronic Hepatitis B Virus Infection. I. Changes in Viral Markers with Interferon Combined with Adenine ArabinosideThe Journal of Infectious Diseases, 1981